MedPath

WellStart Reboot Study

Not Applicable
Withdrawn
Conditions
Type 2 Diabetes Mellitus
Interventions
Behavioral: WellStart
Registration Number
NCT03731533
Lead Sponsor
Ohio University
Brief Summary

This is a randomized, controlled comparison study that will evaluate the effectiveness of WellStart, a virtual intensive therapeutic lifestyle change program to control type 2 diabetes.

Detailed Description

Purpose: To test the efficacy of WellStart Health program to to arrest and / or reverse type 2 diabetes.

Future comparative studies between programs programs are anticipated, utilizing this data to help identify the strengths and weaknesses of different programs, as well as identify subpopulations that might benefit from one program as opposed to another.

Data from this study will be shared via posters and papers among the lifestyle medicine community / publications to help contribute to better lifestyle interventions.

Pilot programs reported on the WellStart web page report reduction in hemoglobin A1c (HBA1c) and weight during the 12 week program.

The web site states:

Evidence for the Program:

The 12-week lifestyle medicine program provides online health coaching and education on 5 domains of wellbeing: whole food, plant-forward nutrition, movement, mindset and social support and resilience. The pilot programs have shown a mean weight reduction of 6.9 lbs in 85% of participants of the 12-week program. 85% of participants with prediabetes experienced a reduction in hemoglobin A1c, while 100% of those with diabetes had a mean hemoglobin A1c reduction of 1.1. WellStart has also helped 35% of participants on pharmacotherapy, eliminate medication (antihypertensives and metformin).

Studies have shown the ability of plant-based nutrition to reverse chronic disease including coronary artery disease. The BROAD study found a statistically significant reduction in BMI and cholesterol in those following a plant-based diet. Furthermore, Dean Ornish's research showed regression of coronary atherosclerosis after 5 years of a plant-based diet in addition to lifestyle changes and found that it reduced cardiac events by half. Caldwell Esselstyn's research on a whole food plant-based diet also demonstrated a significant reduction in major cardiac events in adherent patients.

Furthermore, a 2016 comprehensive literature review supports a plant-based diet as medical nutrition therapy for diabetes based on its ability to reduce fasting blood glucose, hemoglobin A1c, body mass index and reduce medication use.

The Diabetes Prevention Program (DPP), a lifestyle and diet intervention program, reduces the risk of diabetes by half in a population at risk. It has been successfully adapted to the online setting. WellStart is taking this concept a step further by providing participants with additional education and support to transition to plant-forward nutrition habits.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Established diagnosis of type 2 diabetes (T2DM)
  • Between the ages of 18 and 65 years-old
  • Own and willing to use a smart phone or computer, and have daily internet access
  • Have an email account
  • Have access to resources (finances and transportation) that allow for regular acquisition (at least once weekly) of groceries, including produce
  • Access to resources that allow for food preparation at home (refrigeration, basic kitchen appliances and supplies)
  • Willingness to attempt changes in food preparation and consumption, and physical activity.

-Scoring at least a 7/10 in both readiness for change and confidence of success; 1= not ready / no confidence; 10 = extremely ready / extremely confident of success -

Exclusion Criteria
  • Dementia
  • Advanced renal disease (stage 4 or 5) with or without hemodialysis
  • Congestive Heart Failure
  • Taking warfarin
  • Pregnancy or plans for pregnancy
  • Current smoker of tobacco cigarettes
  • Adults who have a physical limitation to prepare their own food or incorporate movement into their lifestyle (based on questionnaire answer)
  • Brittle diabetes and/or history of hospitalization for high or low blood sugar
  • Difficult-to-control hypertension and / or on 4 or more medications for high blood pressure.
  • Does not speak or understand English
  • Inability to use email or the Internet

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
WellStartWellStartWellStart is a 12-week virtual intensive therapeutic lifestyle program utilizing web-based encounters with physicians, dietitians, health coaches and additional resources.
Primary Outcome Measures
NameTimeMethod
Hemoglobin A1c6 months

glycosylated hemoglobin, measure of diabetes control over last 3 months

Weight6 months

risk factor for diabetes

Secondary Outcome Measures
NameTimeMethod
Diastolic Blood Pressure6 months

risk factor for cardiovascular disease, a comorbidity of diabetes

Total cholesterol6 months

risk factor for cardiovascular disease, a comorbidity of diabetes

Systolic Blood Pressure6 months

risk factor for cardiovascular disease, a comorbidity of diabetes

Short Form Health Survey - 36 Questions (SF-36)6 months

Survey of patient health status

Low density lipoprotein cholesterol (calculated)6 months

risk factor for cardiovascular disease, a comorbidity of diabetes

High density lipoprotein cholesterol6 months

risk factor for cardiovascular disease, a comorbidity of diabetes

Triglycerides6 months

risk factor for cardiovascular disease, a comorbidity of diabetes

Days per week of exercise6 months

Average days per week of exercise, self reported by patient

Minutes per day of exercise6 months

Average minutes per day of exercise, self reported by patient

Trial Locations

Locations (1)

Ohio University

🇺🇸

Athens, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath